Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Blake Borgeson currently holds 6,229,863 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Blake Borgeson has been a net seller of RXRX stock. They have purchased $0 and sold $8.9M worth of shares.
Blake Borgeson's most recent insider trade was on Apr 7, 2026, when they sold 30,000 shares at $3.10 per share.
Blake Borgeson serves as Executive at RECURSION PHARMACEUTICALS, INC. (RXRX). They have executed 78 insider transactions totaling $8.9M over their tenure at the company.
Blake Borgeson holds the position of Executive at RECURSION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Blake Borgeson has shown a selling trading pattern, with $0 in total purchases and $8.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Blake Borgeson was on Dec 2, 2025, when they sold $961.4K worth of RXRX shares. This transaction involved 220,000 shares at $4.37 per share.
Blake Borgeson currently owns 6,229,863 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Blake Borgeson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Blake Borgeson has 78 Form 4 filings on record as an insider at RECURSION PHARMACEUTICALS, INC..
Set alerts for Blake Borgeson and 40,000+ other insiders.